The World Market for Next-gen Cancer Diagnostics will reach $1.6Bn in 2015,says new visiongain report

LONDON - Oct. 20, 2015 - PRLog -- PRESS RELEASE: ‘The world market for NEXT-GENERATION CANCER DIAGNOSTICS will reach $1.6 bn in 2015’ SAYS NEW VISIONGAIN REPORT

LONDON, UK. July 27th 2015: A new report by visiongain predicts that the world market for next-generation cancer diagnostics will reach $1.6bn in 2015. This forecast and others appear in Next-Generation Cancer Diagnostics Market Forecast 2015-2025: Opportunities for Leading Companies Developing Advanced PCR Techniques, CTC tests, FISH tests, Microarrays and NGS Technologies published in July 2015. Visiongain is a leading business intelligence provider based in London, UK.

Visiongain estimates that the world next-generation cancer diagnostics market was worth $1,437m in 2014. While the number of new cancer cases is expected to reach 24 million by 2035, the cost savings that could be achieved with early diagnosis will be the main driver for the market. Advances in molecular biology will also help expand the cancer diagnostics test menu. Companies wishing to exploit the cancer diagnostics market will need to investigate different next-generation platforms and their applications for each cancer indication.

Visiongain predicts the market will see rapid growth during the forecast period. Companion cancer diagnostics can be costly but we expect them to be increasingly adopted, particularly when choosing expensive cancer therapies. Laboratory automation, standardised commercial cancer tests and affordable benchtop instruments will continue to reduce the costs of molecular testing.

Developed countries currently represent over 80% of the market. Although growth in 2014 was partially offset by slow economic growth and pricing pressures in healthcare, the current outlook for the global economy is stronger than in 2014. Leading companies, in particular, will experience strong growth in developing markets from 2015 to 2025.

The Next-Generation Cancer Diagnostics Market Forecast 2015-2025: Opportunities for Leading Companies Developing Advanced PCR Techniques, CTC tests, FISH tests, Microarrays and NGS Technologies report will be of value to current and future potential investors into the next-generation cancer diagnostics sector, as well as companies and research centres who wish to broaden their knowledge of the next-generation cancer diagnostics market.

For sample pages and further information concerning the visiongain report Next-Generation Cancer Diagnostics Market Forecast 2015-2025: Opportunities for Leading Companies Developing Advanced PCR Techniques, CTC tests, FISH tests, Microarrays and NGS Technologies please visit https: https://www.visiongain.com/Sector/8/Pharma

For an executive summary please contact:
Email: Sara Peerun on sara.peerun@visiongainglobal.com

Tel: +44 (0) 20 7336 6100

Notes for Editors
If you are interested in a more detailed overview of this report, please send an e-mail to sara.peerun@visiongainglobal.com or call her on +44 (0) 207 336 6100

About Visiongain
Visiongain is one of the fastest growing and most innovative independent media companies in Europe. Based in London, UK, visiongain produces a host of business-2-business conferences, newsletters, management reports and e-zines focusing on the Energy, Telecoms, Pharmaceutical, Defence, Materials sectors.

Visiongain publishes reports produced by its in-house analysts, who are qualified experts in their field. Visiongain has firmly established itself as the first port-of-call for the business professional, who needs independent, high quality, original material to rely and depend on.